Inna Kleyman, MD, shares why she joined Velocity, a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUMC.
Collaboration will investigate a system biology approach to identifying treatment options for patients with advanced gastrointestinal stromal tumors (GIST).
Columbia University researchers have created a user-friendly program that rapidly predicts which genes are implicated in an individual’s cancer and recommends treatments.
Researchers have found that blocking nerve growth factor inhibits the formation of stomach cancers, according to a study in mice.
In a phase 1 study, eight out of 12 patients with relapsed and/or refractory blood cancers responded to a combination of two common chemotherapy drugs.
Three CUMC scientists have been named AAAS Fellows: Max Gottesman, Wei Gu, and Paul Sajda.